Show simple item record

dc.contributor.authorSagrera, Mònica
dc.contributor.authorSibila, Marina
dc.contributor.authorMartínez-Boixaderas, Núria
dc.contributor.authorLlorens, Anna Maria
dc.contributor.authorEspigares, David
dc.contributor.authorPastor, Josep
dc.contributor.authorGarza-Moreno, Laura
dc.contributor.authorSegalés, Joaquim
dc.contributor.otherProducció Animalca
dc.date.accessioned2024-10-23T16:45:02Z
dc.date.available2024-10-23T16:45:02Z
dc.date.issued2024-08-23
dc.identifier.citationSagrera, Mònica, Marina Sibila, Núria Martínez-Boixaderas, Anna Maria Llorens, David Espigares, Josep Pastor, Laura Garza-Moreno, and Joaquim Segalés. 2024. “Can Immunocrit Be Used as a Monitoring Tool for Swine Vaccination and Infection Studies?” Porcine Health Management 10 (1). https://doi.org/10.1186/s40813-024-00380-y. ‌ca
dc.identifier.issn2055-5660ca
dc.identifier.urihttp://hdl.handle.net/20.500.12327/3346
dc.description.abstractBackground The immunocrit is a cost-effective and straightforward technique traditionally used to assess passive immunity transfer to newborn piglets. However, it has not been previously used for monitoring the effect of vaccination and/or infections. Therefore, this study aimed to evaluate the usefulness of the immunocrit technique as an immunological monitoring tool in a vaccination and challenge scenario, using porcine circovirus 2 (PCV-2) as pathogen model. The immunocrit ratio was monitored in PCV-2 vaccinated (V) and non-vaccinated (NV) 3-week-old piglets (study day 0, SD0) that were subsequently challenged with this virus at SD21 and followed up to SD42. Additional techniques (PCV-2 IgG ELISA, optical refractometry, and proteinogram) were performed to further characterize the results of the immunocrit analysis. Results Immunocrit, γ-globulin concentration and PCV-2 S/P values followed similar dynamics: descending after PCV-2 vaccination but ascending after an experimental PCV-2 inoculation. However, statistically significant differences between V and NV animals were only found with the PCV-2 ELISA. In this case, V animals had significantly higher (p < 0.05) S/P values (S/P ratio = 0.74) than NV (S/P ratio = 0.39) pigs only after challenge at SD42. On the other hand, serum total protein obtained by refractometer (STPr) were maintained from SD0 to SD21 and increased in both groups from SD21 to SD42. Correlations between techniques were low to moderate, being the most robust ones found between immunocrit and optical refractometry (ρ = 0.41) and immunocrit with γ-globulins (ρ = 0.39). In a subset of sera, the proteinogram technique was applied to the whole serum and the supernatant of the immunocrit, with the objective to characterize indirectly the immunocrit fraction. The latter one included all protein types detectable through the proteinogram, with percentages varying between 64.3% (γ-globulins) and 82% (β-globulins). Conclusion The immunocrit technique represented a fraction of the total serum proteins, with low to moderate correlation with all the complementary techniques measured in this study. Its determination at different time points did not allow monitoring the effect of vaccination and/or infection using PCV-2 as a pathogen model.ca
dc.format.extent9ca
dc.language.isoengca
dc.publisherBMCca
dc.relation.ispartofPorcine Health Managementca
dc.rightsAttribution 4.0 Internationalca
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleCan immunocrit be used as a monitoring tool for swine vaccination and infection studies?ca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc619ca
dc.identifier.doihttps://doi.org/10.1186/s40813-024-00380-yca
dc.contributor.groupSanitat Animalca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint